Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Replimune Inc.
Myeloid Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Nanobiotix
Memgen, Inc.
Mayo Clinic
Exelixis
Daiichi Sankyo
Compugen Ltd
Eli Lilly and Company
Astellas Pharma Inc
OHSU Knight Cancer Institute
Fate Therapeutics
Jonsson Comprehensive Cancer Center
Tempest Therapeutics
Fate Therapeutics
Calithera Biosciences, Inc
Bristol-Myers Squibb
Infinity Pharmaceuticals, Inc.
Sheba Medical Center
Celgene